HomeNews

News

Taking Time to ‘Scent the Roses’

Jane Biehl is a 12-year survivor of a really uncommon type of blood most cancers, generally known as myelodysplastic syndrome (MDS). Compensate for all...

Addressing Execs and Cons of CAR-T Cell Remedy in Melanoma

For sufferers with melanoma, remedy with CAR-T cell remedy could come together with execs and cons to contemplate.T-cells are immune cells that acknowledge...

Nivolumab and AVD the New Customary in Hodgkin Lymphoma

November 14, 2024, ...

A Section 3 Trial of Amezalpat in Superior Liver Most cancers Receives Examine Could Proceed Letter

The Meals and Drug Administration (FDA) issued a “Examine Could Proceed” letter, permitting a part 3 trial to guage first-line therapy with amezalpat...

Managing Trodelvy’s Facet Results By Dose Adjustment

Trodelvy (sacituzumab govitecan), the usual remedy for triple-negative breast most cancers, provides hope for improved survival, however comes with the problem of managing...

Hot Topics